Jennifer Perone, MD
Surgical Oncology · Baton Rouge, LANPI 1518303106
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 61.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $2,126 and has fallen 99.0% since, to $21 in 2025.
Across 22 payments — averaging $145.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Medtronic$582
- KCI USA, Inc.$200
- Baxter Healthcare$172
- E.r. Squibb & Sons, L.L.C.$123
- Johnson & Johnson$98
- plus $76 from 3 others
What the payments were for
- Travel & lodging$92429%
- Food & beverage$1,28040%
- Education$1,00031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $1,953 |
| Medtronic | 8 | $582 |
| KCI USA, Inc. | 1 | $200 |
| Baxter Healthcare | 2 | $172 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Johnson & Johnson | 1 | $98 |
| Boston Scientific | 1 | $31 |
| Incyte Corporation | 1 | $23 |
| Acera Surgical, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
- Da Vinci Surgical System$899
- Signia$376
- VAC ULTA$200
- VAC VERAFLO CLEANSE CHOICE$200
- PREVENA$200
- VAC VERAFLO$200
- ARTISS$124
- OPDIVO$123
How this compares
$3,204 in reported general payments places this provider in the 55th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 27 | $61 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Baton Rouge
- Peter BostickBaton Rouge$7K
- Lindsey FauveauBaton Rouge$4K
- Robert ElliottBaton Rouge$101
- Michael HaileyBaton Rouge$53
- Emery MinnardGretna$183K
- Mary Hobbs-MaluccioMetairie$41K
- Terry LairmoreShreveport$13K
- Nathan BoltonNew Orleans$6K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.